Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors

Calithera Biosciences, Inc · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
colorectal-cancer
solid tumor, clear cell renal cell carcinoma, tnbc - triple-negative breast cancer, colorectal cancer, crc, rcc, ccrcc, tumor metabolism, glutaminase inhibitor, cb-839, telaglenastat, talazoparib
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 904379
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.